Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Peter Blanckaert
Profile
Projects
Publications
Activities
Awards & Distinctions
34
Results
2021
Opt-out design for an observational toxicology study involving intoxicated patients at a dance music event
Paul Calle
PETER BLANCKAERT
SABINE LEMOYNE
Robert Rubens
A2
Journal Article
in
ETHICS & HUMAN RESEARCH
2021
2014
Belgian national report on drugs 2014, new developments and trends
Els Plettinckx
PETER BLANCKAERT
K De Ridder
Freya Vander Laenen
F Laudens
L Casero
L Gremeaux
Report
2014
2012
Tissue perfusion in pathologies of the pancreas: assessment using 128-slice computed tomography
Louke Delrue
PETER BLANCKAERT
Dokus Mertens
STEPHEN VAN MEERBEECK
Wim Ceelen
Philippe Duyck
A1
Journal Article
in
ABDOMINAL IMAGING
2012
2011
Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights
Louke Delrue
Veerle Casneuf
Nancy Van Damme
PETER BLANCKAERT
Marc Peeters
Wim Ceelen
Philippe Duyck
A1
Journal Article
in
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE
2011
Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging
Louke Delrue
PETER BLANCKAERT
Dokus Mertens
Ercan Cesmeli
Wim Ceelen
Philippe Duyck
A1
Journal Article
in
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
2011
The impact of HF-rTMS treatment on serotonin2A receptors in unipolar melancholic depression
Chris Baeken
Rudi De Raedt
Axel Bossuyt
Christian Vanhove
John Mertens
André Dobbeleir
PETER BLANCKAERT
Ingeborg Goethals
A1
Journal Article
in
BRAIN STIMULATION
2011
Variability of CT contrast enhancement in the pancreas : a cause for concern?
Louke Delrue
PETER BLANCKAERT
Dokus Mertens
Jan De Waele
Wim Ceelen
Eric Achten
Philippe Duyck
A1
Journal Article
in
PANCREATOLOGY
2011
2009
Effect of cyclosporin A administration on the biodistribution and multipinhole μSPECT imaging of [123-I]R91150 in rodent brain
PETER BLANCKAERT
Ingrid Burvenich
Steven Staelens
SYLVIE DE BRUYNE
Lieselotte Moerman
Leonie Wyffels
Filip De Vos
A1
Journal Article
in
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2009
Radiosynthesis, in vitro and in vivo evaluation of 123I-labeled anandamide analogues for mapping brain FAAH
Leonie Wyffels
SYLVIE DE BRUYNE
PETER BLANCKAERT
Didier M Lambert
Filip De Vos
A1
Journal Article
in
BIOORGANIC & MEDICINAL CHEMISTRY
2009
2008
In vivo evaluation in rodents of [I-123]-3-I-CO as a potential SPECT tracer for the serotonin 5-HT2A receptor
PETER BLANCKAERT
Ingrid Burvenich
Leonie Wyffels
SYLVIE DE BRUYNE
Lieselotte Moerman
Filip De Vos
A1
Journal Article
in
NUCLEAR MEDICINE AND BIOLOGY
2008
Synthesis and in vivo evaluation of [123I]-3-I-CO: a potential SPECT tracer for the serotonin 5-HT2A receptor
PETER BLANCKAERT
Filip De Vos
Dissertation
2008
2007
Biodistribution and planar gamma camera imaging of I-123- and I-131-labeled F(ab ')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor
Ingrid Burvenich
Steve Schoonooghe
PETER BLANCKAERT
Klaus Bacher
Liesbet Vervoort
Elisabeth Coene
Nico Mertens
Filip De Vos
Guido Slegers
A1
Journal Article
in
NUCLEAR MEDICINE AND BIOLOGY
2007
Synthesis and in vivo evaluation in mice of (I-123)-(4-fluorophenyl)(1-(3-iodophenethyl)piperidin-4-yl) methanone as a potential SPECT-tracer for the serotonin 5-HT2A receptor
PETER BLANCKAERT
I. Burvenich
F. Devos
G. Slegers
A1
Journal Article
in
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
2007
2006
Regional cerebral bloodflow and binding index of the 5-HT2A receptor in dogs with anxiety disorder
Kathelijne Peremans
Rudy De Meester
PETER BLANCKAERT
André Dobbeleir
Eva Vandermeulen
Ingeborg Goethals
Tim Waelbers
Filip De Vos
Kurt Audenaert
C1
Conference
2006
Serotonin-2A binding index of the 5-HT2A receptor in dogs with anxiety disorder
Kathelijne Peremans
Rudy De Meester
PETER BLANCKAERT
André Dobbeleir
Eva Vandermeulen
Ingeborg Goethals
Tim Waelbers
Filip De Vos
Kurt Audenaert
C3
Conference
2006
2005
In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model
Ingrid Burvenich
Steve Schoonooghe
Bart Cornelissen
PETER BLANCKAERT
Elisabeth Coene
Claude Cuvelier
Nico Mertens
Guido Slegers
A1
Journal Article
in
CLINICAL CANCER RESEARCH
2005
In vivo evaluation of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno [3,4-c]pyridin-5-one: a presumed dopamine D-4 receptor ligand for SPECT studies
Ludovicus Staelens
Ruth Oltenfreiter
PETER BLANCKAERT
Veerle Kersemans
KATIA VANDENBULCKE
Christophe Van De Wiele
Guido Slegers
A1
Journal Article
in
NUCLEAR MEDICINE AND BIOLOGY
2005
In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies
Ludovicus Staelens
Ruth Oltenfreiter
Filip Dumont
RN WATERHOUSE
K VANDENBULCKE
PETER BLANCKAERT
Rudi Dierckx
Guido Slegers
A1
Journal Article
in
NUCLEAR MEDICINE AND BIOLOGY
2005
Synthesis of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno[3,4-c]pyri din-5-one, a potential dopamine D4 ligand for SPECT studies
Ludovicus Staelens
Ruth Oltenfreiter
Bart Cornelissen
PETER BLANCKAERT
Filip De Vos
Dieter Deforce
Rudi Dierckx
Guido Slegers
A1
Journal Article
in
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
2005
Synthesis, radiosynthesis and in vivo evaluation in mice of [I-123]-(4-fluorophenyl) {1-[2-(4-iodophenyl)ethyl]piperidin-4-yl}methanone for visualization of the 5-HT2A receptor with SPECT
PETER BLANCKAERT
Ingrid Burvenich
Ludovicus Staelens
Rudi Dierckx
Guido Slegers
A1
Journal Article
in
APPLIED RADIATION AND ISOTOPES
2005
2004
123I-labelled monoclonal antibody 14C5 for SPECT tumour imaging: In vivo evaluation of athymic mice bearing a LoVo tumour
Ingrid Burvenich
Bart Cornelissen
PETER BLANCKAERT
Elisabeth Coene
Claude Cuvelier
Guido Slegers
Steve Schoonooghe
Nico Mertens
C1
Conference
2004
Improved targeting with F(ab)2 fragments of monoclonal antibody 14C5 for imaging and therapy of metastatic disease
Ingrid Burvenich
Karen Janssen
PETER BLANCKAERT
Steve Schoonooghe
Elisabeth Coene
Claude Cuvelier
Nico Mertens
Guido Slegers
C3
Conference
2004
In vitro evaluatie van 14C5 monoklonaal antilichaamderivaten voor gebruik in radioimmunodiagnostiek en radioimmunotherapie
Ingrid Burvenich
KAREN JANSSEN
PETER BLANCKAERT
Guido Slegers
C1
Conference
2004
Internalization and cellular processing of radiolabeled monoclonal antibody 14C5
Ingrid Burvenich
Steve Schoonooghe
Ruth Oltenfreiter
PETER BLANCKAERT
E COENE
Claude Cuvelier
N MERTENS
Guido Slegers
C1
Conference
2004
Precursor synthesis, radiosynthesis and in vivo evaluation in mice of [I-123]-(4-fluorophenyl) {1-[2-(2-iodophenyl)ethyl]piperidin-4-yl}-methanone and -methanol, as potential SPECT tracers for the 5-HT2A-receptor
PETER BLANCKAERT
M Vandecapelle
Ingrid Burvenich
Ludovicus Staelens
Guido Slegers
C3
Conference
2004
Synthese van de precursor, radiosynthese en in vivo evaluatie in muizen van [123I]-(4-fluorofenyl){1-[2-(4-iodofenyl)ethyl]piperidin-4-yl}methanon, als potentiële SPECT ligand voor de 5-HT2A-receptor
PETER BLANCKAERT
Ine Patou
Marleen Vandecapelle
Ingrid Burvenich
Guido Slegers
C1
Conference
2004
Synthesis and preliminary in vivo evaluation of [18F] labelled derivatives of Org 13063 as potential PET radioligands for the 5-HT1A receptor
MN Vandecapelle
Filip Dumont
PETER BLANCKAERT
Filip De Vos
Karel Strijckmans
DCM Leysen
Kurt Audenaert
Rudi Dierckx
Guido Slegers
C3
Conference
2004
Synthesis, radiosynthesis and preliminary in vivo evaluation of [123I]-(1-(5-iodo-2-methoxyphenethyl)piperidin-4-yl)(4-fluorophenyl)methanone as a potential SPECT tracer for visualizing the 5-HT2A-receptor
PETER BLANCKAERT
Ingrid Burvenich
Guido Slegers
C1
Conference
2004
Synthesis, radiosynthesis and preliminary in vivo evaluation of [I-123](4-fluorophenyl) {1-[2-(2(2-iodophenyl)ethyl]piperidin-4-yl}methanone, a potential 5-HT2A-antagonist for SPECT brain imaging
PETER BLANCKAERT
Marleen Vandecapelle
Ludovicus Staelens
Ingrid Burvenich
Rudi Dierckx
Guido Slegers
A1
Journal Article
in
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
2004
Targeting properties of radiolabelled monoclonal antibody 14c5 directed against a cell substrate adhesion molecule
Ingrid Burvenich
Steve Schoonooghe
PETER BLANCKAERT
Elisabeth Coene
Bart Cornelissen
Claude Cuvelier
Nico Mertens
Guido Slegers
C1
Conference
2004
2003
Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150
Kathelijne Peremans
Kurt Audenaert
Frank Coopman
PETER BLANCKAERT
Filip Jacobs
Andreas Otte
Francis Verschooten
Henri van Bree
Cornelis Van Heeringen
John Mertens
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2003
Evaluation of the aging brain with single photon emission tomography
Kathelijne Peremans
Kurt Audenaert
Frank Coopman
PETER BLANCKAERT
Filip Jacobs
Guido Slegers
Francis Verschooten
Henri van Bree
Rudi Dierckx
C3
Conference
2003
Regional cerebral bloodflow and binding index of the 5-Ht2A receptor in the impulsive aggressive dog treated with citalopram
Kathelijne Peremans
Kurt Audenaert
Yves Hoybergs
Filip Jacobs
PETER BLANCKAERT
Francis Verschooten
Henri van Bree
Guido Slegers
Rudi Dierckx
C3
Conference
2003
2002
Effects of aging on brain perfusion and serotonin-2A receptor binding in the normal canine brain measured with single photon emission tomography.
Kathelijne Peremans
Kurt Audenaert
PETER BLANCKAERT
Filip Jacobs
Frank Coopman
Francis Verschooten
Henri van Bree
Cornelis Van Heeringen
John Mertens
Guido Slegers
et al.
A1
Journal Article
in
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
2002